Extend Biosciences, Inc.

Extend Biosciences is a clinical-stage biotechnology company developing a drug delivery platform technology called D-VITylation® that extends the circulating half-life and bioavailability of peptides and proteins for therapeutic use. The company's technology addresses the challenge of peptides being rapidly removed from circulation by enabling the development of longer-acting peptide-based drugs.